Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nanomedicine

• Publication date

  2009-10-20

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.2217/nnm.09.65PMID 19839810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantifying drug release from PLGA nanoparticulates.

  2009cited by this paper
• Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.

  2008cited by this paper
• Model-based assessment for human inhalation exposure risk to airborne nano/fine titanium dioxide particles.

  2008cited by this paper
• Role of metalloproteinases in platelet function.

  2008cited by this paper
• Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA.

  2006cited by this paper
• Biocompatible, Hydrophilic, Supramolecular Carbon Nanoparticles for Cell Delivery

  2006cited by this paper
• Selectins--potential pharmacological targets?

  2006cited by this paper
• Double functionalization of carbon nanotubes for multimodal drug delivery.

  2006cited by this paper
• Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates.

  2006cited by this paper
• Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials.

  2005cited by this paper
• Formulation and process parameters affecting protein encapsulation into PLGA microspheres during ethyl acetate-based microencapsulation process

  2005cited by this paper
• Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles

  2005cited by this paper
• Nanoparticle‐induced platelet aggregation and vascular thrombosis

  2005cited by this paper
• Novel Chitosan Particles and Chitosan-Coated Emulsions Inducing Immune Response via Intranasal Vaccine Delivery

  2004cited by this paper
• Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms.

  2004cited by this paper
• Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.

  2004cited by this paper
• Chitosan Nanoparticles for Plasmid DNA Delivery: Effect of Chitosan Molecular Structure on Formulation and Release Characteristics

  2004cited by this paper
• Involvement of the Antiplatelet Activity of Magnesium Sulfate in Suppression of Protein Kinase C and the Na+/H+ Exchanger

  2004cited by this paper
• Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects.

  2003cited by this paper
• The Importance of Surface Area and Specific Reactivity in the Acute Pulmonary Inflammatory Response to Particles

  2002cited by this paper
• Ultrafine particles affect experimental thrombosis in an in vivo hamster model.

  2002cited by this paper
• Design of biodegradable particles for protein delivery.

  2002cited by this paper
• Mechanisms of action of proteinase‐activated receptor agonists on human platelets

  2002cited by this paper
• Passage of Inhaled Particles Into the Blood Circulation in Humans

  2002cited by this paper
• The surface area rather than the surface coating determines the acute inflammatory response after instillation of fine and ultrafine TiO2 in the rat.

  2002cited by this paper
• Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.

  2001cited by this paper
• Chitosan and its use as a pharmaceutical excipient.

  1998cited by this paper
• Platelet adhesion onto segmented polyurethane surfaces modified by PEO- and sulfonated PEO-containing block copolymer additives.

  1998cited by this paper
• Alginate and chitosan: Biodegradable biopolymers in drug delivery systems

  1996cited by this paper
• Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs

  1996cited by this paper
• Protein adsorption, lymphocyte adhesion and platelet adhesion/activation on polyurethane ureas is related to hard segment content and composition.

  1994cited by this paper
• Determination of degree of deacetylation of chitosan by 1H NMR spectroscopy

  1991cited by this paper
• Mechanisms of blood coagulation induced by latex particles and the roles of blood cells.

  1990cited by this paper
• Platelet aggregation induced by latex particles. I. Effects of size, surface potential and hydrophobicity of particles.

  1989cited by this paper
• Effects of synthetic human gastrin-releasing peptide on pancreatic exocrine secretion and release of pancreatic polypeptide in conscious rats

  1989cited by this paper
• STUDY OF PLATELET ADHESIVENESS AND AGGREGATION, WITH LATEX PARTICLES.

  1965cited by this paper
• On the reaction of the thrombocytes to submicroscopic particles in vitro.

  1955cited by this paper

• Peripheral artery disease and local drug delivery: a review of disease pathology and drug delivery systems for therapy below the knee

  2025cites this paper
• A double‐edged sword: The complex interplay between engineered nanoparticles and platelets

  2024cites this paper
• Cutting-edge advances in nano/biomedicine: A review on transforming thrombolytic therapy.

  2024cites this paper
• Mapping the evolution of inhaled drug delivery research: Trends, collaborations, and emerging frontiers.

  2023cites this paper
• Assessment of the effect of polymeric nanoparticles on storage and stability of blood products (red blood cells, plasma, and platelet)

  2022cites this paper
• Effects of nanoparticles on the blood coagulation system (nanoparticle interface with the blood coagulation system)

  2022cites this paper
• Assessment of Physicochemical and In Vivo Biological Properties of Polymeric Nanocapsules Based on Chitosan and Poly(N-vinyl pyrrolidone-alt-itaconic anhydride)

  2022cites this paper
• Biocompatibility study of P (N-isopropylacrylamide)-based nanocomposite and its cytotoxic effect on HeLa cells as a drug delivery system for Cisplatin

  2022cites this paper
• Influence of nanoparticles on the haemostatic balance: between thrombosis and haemorrhage.

  2021cites this paper
• Biophysical interaction, nanotoxicology evaluation, and biocompatibility and biosafety of metal nanoparticles

  2021cites this paper
• Drug Carriers: Classification, Administration, Release Profiles, and Industrial Approach

  2021cites this paper
• Recent update of toxicity aspects of nanoparticulate systems for drug delivery.

  2021cites this paper
• Nanomedicine progress in thrombolytic therapy.

  2020cites this paper
• The effect of size and surface ligands of iron oxide nanoparticles on blood compatibility

  2020cites this paper
• CYTOTOXICITY AND HEMOCOMPATIBILITY OF DOXORUBICIN-LOADED PLGA NANOPARTICLES

  2020cites this paper
• PLGA-PEG Nanoparticles Show Minimal Risks of Interference with Platelet Function of Human Platelet-Rich Plasma

  2020influential citation
• Biological Safety and Biodistribution of Chitosan Nanoparticles

  2020cites this paper
• Poly(acrylic acid)-Coated Iron Oxide Nanoparticles interact with mononuclear phagocytes and decrease platelet aggregation.

  2019cites this paper
• Title The use of quartz crystal microbalance with dissipation ( QCM-D ) for studying nanoparticle-induced platelet aggregation

  2019cites this paper
• The effects of nanomaterials on blood coagulation in hemostasis and thrombosis.

  2017cites this paper
• Magnetic nanoparticles for drug targeting: from design to insights into systemic toxicity. Preclinical evaluation of hematological, vascular and neurobehavioral toxicology.

  2017cites this paper
• Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.

  2017cites this paper
• Toxicological Aspects of Polymer Nanoparticles

  2016cites this paper
• Magnetically controlled release of recombinant tissue plasminogen activator from chitosan nanocomposites for targeted thrombolysis.

  2016cites this paper
• Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation

  2016cites this paper
• Evaluating the Interactions Between Proteins and Components of the Immune System with Polymer Nanoparticles

  2016cites this paper
• The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges.

  2016cites this paper
• Nanotoxicology of Nanomaterials : New Opportunities and Challenges

  2016cites this paper
• Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.

  2015cites this paper
• Interactions of stealth conjugated polymer nanoparticles with human whole blood.

  2015cites this paper
• Pegylation increases platelet biocompatibility of gold nanoparticles.

  2014cites this paper
• Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo

  2013cites this paper
• Platelets, photosensitizers, and PDT.

  2013cites this paper
• Title: PEGYLATION INCREASES PLATELET BIOCOMPATIBILITY OF GOLD NANOPARTICLES (13-518-R)

  2013cites this paper
• Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia

  2013cites this paper
• Blood protein and blood cell interactions with gold nanoparticles: the need for in vivo studies

  2013cites this paper
• The Effects of Engineered Nanomaterials on Platelets

  2013cites this paper
• Hematotoxicological analysis of surface-modified and -unmodified chitosan nanoparticles.

  2013cites this paper
• Immunological Properties of Engineered Nanomaterials: An Introduction

  2012cites this paper
• Encapsulation and Controlled Release of rHu-Erythropoietin from Chitosan Biopolymer Nanoparticles

  2012cites this paper
• Thrombotic Inception at Nano-Scale

  2012influential citation
• The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregation

  2012cites this paper
• Investigation of the interaction of biodegradable micro‐ and nanoparticulate drug delivery systems with platelets

  2011influential citation
• FORUM EKSPERTÓW A nanoscale resolution assay of flow-induced platelet microaggregation

  2011cites this paper
• Standardization of models and methods used to assess nanoparticles in cardiovascular applications.

  2011cites this paper
• A nanoscale resolution assay of flow-induced platelet microaggregation Mikroagregacja płytek indukowana przepływem - badanie w nanorozdzielczości

  2010cites this paper
• One kind of nanoparticle preparation for the treatment of brain diseases

  2010cites this paper